Loading...
Loading...
XXII| Name | Value |
|---|---|
| Revenues | 7.9M |
| Cost of Revenue | 23.3M |
| Gross Profit | -15.5M |
| Operating Expense | 46.2M |
| Operating I/L | -48.1M |
| Other Income/Expense | -1.2M |
| Interest Income | 0.1M |
| Pretax | -72.7M |
| Income Tax Expense | -1.6M |
| Net Income/Loss | -72.7M |
22nd Century Group, Inc. is an agricultural biotechnology company specializing in tobacco harm reduction and plant science for life science and consumer products industries. The company develops very low nicotine content tobacco and cigarette products, including VLN King and VLN Menthol King, as well as SPECTRUM research cigarettes for clinical studies. Additionally, it collaborates with Keygene N.V. to develop hemp/cannabis plants with exceptional cannabinoid profiles and superior agronomic traits for medical, therapeutic, and agricultural uses.
